Satish graduated from the University of Edinburgh Medical School in 1996. His basic surgical training was at the University Hospital of Wales in Cardiff. After a 2 year period of research in Bladder and Prostate cancer with Cancer Research UK, based at the Christie Hospital in Manchester, Satish gained the higher degree of MD in targeted therapies in the treatment of muscle invasive bladder cancer affiliated to the University of Manchester.
His higher specialist Urology training has been undertaken in the North West Deanery with specialist urological oncology surgical training throughout at tertiary cancer centres.
Satish has also undertaken further training in laparoscopic radical bilateral nerve sparing prostatectomy at the Erasmus University in Brussels, Belgium under the mentorship of one of Europe’s leading minimally invasive laparoscopic prostate cancer surgeons.
Satish was appointed as a Consultant Urological Surgeon at Mid Cheshire NHS Foundation Trust where he was the Cancer Lead and subsequently the Clinical Lead for the Urology department. He was involved with the successful amalgamation of urological cancer services with Stockport NHS Trust.
Relocating to Manchester, Satish was appointed as the Urology Cancer Lead at Salford Royal NHS Foundation Trust, one of the North West’s premier urological units and NHS Trusts. Here he is the lead robotic surgeon and mentors trainees and fellow surgeons and is a recognised Intuitive Da Vinci European Robotic Procter. He also chairs the Robot Programme Board to initiate and help develop further implementation of innovative robot assisted surgical techniques at the trust.
Satish is a member of the NHSE Prostate Cancer Clinical Expert Group (affiliated with Prostate Cancer UK) helping to guide the direction of prostate cancer management in England & Wales. He is also a member of the NCRI Renal Cancer Surgical Research Group which oversees clinical trials for renal cancer patients.
Satish is the Director for Urological Cancer services for Greater Manchester Cancer, the largest cancer network outside London. In this role he has innovated contemporary urological cancer services for Manchester over the last 7 years. As Director of the Urology pathway board for GM he is responsible for clinical oversight of cancer care and the introduction of multiple diagnostic and treatment initiatives for urological patients.
Satish has chaired the NHS England commissioned Vanguard task force reviewing prostate cancer diagnostics across England (working closely with colleagues from The Royal Marsden and UCLH). Through this group, NHS England is now implementing the use of MRI prostate scans to improve the diagnosis of prostate cancer. Satish lead the implementation of this in Greater Manchester with the introduction of the straight to MRI diagnostic prostate cancer pathway in the cancer network.
Satish has also introduced the latest prostate biopsy techniques to Manchester through his role as Implementation lead for the Best Timed Prostate Pathway (#BTiPP). The latest techniques incorporate MRI scans and a new, safer and more accurate form of targeted prostate biopsy. Through the acquisition of NHSE Transformation funding he has implemented both modalities across Manchester to vastly improve the patient experience of the suspected prostate cancer pathway.
Satish has also recently been successfully awarded an NHSE Covid Recovery Funding grant to implement a new technique in the treatment of superficial bladder cancer under local anaesthetic. Along with colleagues, he is implementing this new laser ablation technique (TULA) for bladder cancer treatment across the Northern Care Alliance (a newly formed NHS trust in Manchester serving a population of 1 million in the north of the conurbation).
Satish has been appointed the Chief of Surgery for the Northern Care Alliance (NCA), one of the largest NHS Trusts in the UK. In this role he is responsible for all surgical services across a group of 4 hospitals spanning the northern half of Greater Manchester.